
Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
Portland, OR-Hormone replacement therapy (HRT) does not appear to alter the incidence of dry eye symptoms or physiologic dry eye in women prior to or during menopause, according to Oregon researchers.